[SCHEDULE 13G/A] Genesco Inc. SEC Filing

Rhea-AI Filing Summary

Nomura Holdings, Inc. and its subsidiary Nomura Global Financial Products, Inc. report beneficial ownership of Genesco Inc. common stock totaling 422,732 shares (Nomura Holdings) and 422,678 shares (NGFP) with shared voting and dispositive power. The reported holdings represent 3.9% of Genesco's outstanding shares, calculated on a base of 10,778,805 shares as disclosed in the issuer's quarterly report as of May 30, 2025. The filing indicates the shares are held in the ordinary course of business and were not acquired to influence control of the issuer. Exhibits include a joint filing agreement and a list of subsidiaries.

Positive

• Transparent disclosure of beneficial ownership amounts and the basis for the percentage calculation
• Holdings are below 5%, indicating no current intention to influence control according to the filing

Negative

• None.

Insights

Financial Analyst

TL;DR: Nomura reports a modest 3.9% position in Genesco held with shared voting and dispositive power; impact is neutral.

The disclosed stake of 422,732 shares is below the typical 5% reporting threshold for substantial influence, indicating a non-controlling economic exposure. Shared voting and dispositive power suggests the position may be held through affiliated trading or structured products rather than direct long-term strategic ownership. For investors, this filing documents ownership concentration but does not signal a change in control or a material shift in governance.

Corporate Governance Expert

TL;DR: Reporting shows shared authority over a sub-5% stake; governance implications are limited and routine.

The form states the holdings are not intended to influence control and are held in the ordinary course of business. Because voting and dispositive power are shared and the percentage of class is 3.9%, there is no immediate governance risk or activist signal evident from this disclosure. Exhibits identifying subsidiaries and a joint filing agreement are standard for parent-subsidiary reporting.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

GENESCO INC

(Name of Issuer)

Common Stock, $1.00 par value

(Title of Class of Securities)

371532102

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 371532102

1

Names of Reporting Persons

NOMURA HOLDINGS INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

JAPAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 422,732.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 422,732.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

422,732.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.9 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: (1) Shared voting and dispositive power represents (i) 422,678 shares of Common Stock beneficially owned by Nomura Global Financial Products, Inc. ("NGFP") and (ii) 54 shares of Common Stock beneficially owned by Nomura Securities International, Inc. ("NSI"). NGFP and NSI are wholly owned subsidiaries of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the shares of Common Stock beneficially owned by NGFP and NSI. (2) The percent of class is calculated based on 10,778,805 shares of Common Stock outstanding as of May 30, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended May 3, 2025 filed with the SEC on June 12, 2025.

SCHEDULE 13G

CUSIP No. 371532102

1

Names of Reporting Persons

NOMURA GLOBAL FINANCIAL PRODUCTS INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 422,678.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 422,678.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

422,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.9 %

12

Type of Reporting Person (See Instructions)

BD

Comment for Type of Reporting Person: (3) The percent of class is calculated based on 10,778,805 shares of Common Stock outstanding as of May 30, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended May 3, 2025 filed with the SEC on June 12, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GENESCO INC
(b)	Address of issuer's principal executive offices: 535 Marriott Drive, Nashville, Tennessee, 37214
Item 2.
(a)	Name of person filing: Nomura Holdings, Inc. Nomura Global Financial Products, Inc.
(b)	Address or principal business office or, if none, residence: Nomura Holdings, Inc.: 13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan Nomura Global Financial Products, Inc.: Worldwide Plaza 309 West 49th Street New York, NY 10019
(c)	Citizenship: Nomura Holdings, Inc.: Japan Nomura Global Financial Products, Inc.: Delaware
(d)	Title of class of securities: Common Stock, $1.00 par value
(e)	CUSIP No.: 371532102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Items 5-11 of the cover pages are incorporated by reference.
(b)	Percent of class: Items 5-11 of the cover pages are incorporated by reference.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Items 5-11 of the cover pages are incorporated by reference.
	(ii) Shared power to vote or to direct the vote: Items 5-11 of the cover pages are incorporated by reference.
	(iii) Sole power to dispose or to direct the disposition of: Items 5-11 of the cover pages are incorporated by reference.
	(iv) Shared power to dispose or to direct the disposition of: Items 5-11 of the cover pages are incorporated by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit B
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NOMURA HOLDINGS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Managing Director
Date:	08/14/2025

NOMURA GLOBAL FINANCIAL PRODUCTS INC

Signature:	/s/ Samir Patel
Name/Title:	Samir Patel, Authorized Officer
Date:	08/14/2025

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Subsidiaries

FAQ

How many Genesco (GCO) shares does Nomura report owning?

The filing reports Nomura beneficially owns 422,732 shares in total and NGFP specifically owns 422,678 shares.

What percentage of Genesco does Nomura's position represent?

The reported holdings represent 3.9% of Genesco's outstanding common stock based on 10,778,805 shares outstanding.

Does Nomura claim voting or dispositive control over the shares?

Yes; the filing reports shared voting power and shared dispositive power over the reported shares.

Is Nomura attempting to influence Genesco's control according to the filing?

No; the certification states the securities are held in the ordinary course of business and were not acquired to influence control.

What exhibits accompany the Schedule 13G/A filing?

Exhibits listed include a Joint Filing Agreement and a schedule of Subsidiaries.